Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.

TSX:SVA - Post by User

Sernova Corp > New Press Release - Sernova Corp. Announces Change of Auditor

<< Previous

Bullboard Posts

Next >>

Comment by MustangSalleyon Oct 24, 2022 1:00pm

174 Views

Post# 35044120

RE:RE:RE:New Press Release - Sernova Corp. Announces Change of Auditor

But Bioteck, a big league accounting firm means that Sva is now the real deal and they must have a top tier firm to do a deal or potential buy out by pharma. Stop being silly Bioteck, don't you see the big moves happening for the take out. They should of halted the stock for this news release .. I mean it might of stopped the sudden movement of share price.

<< Previous

Bullboard Posts

Next >>

One of the strongest contenders to lead Canada’s cannabis market